Letter

Into the therapeutics void

A lecturer from BSMS explains

BMJ 2009; 338 doi: 10.1136/bmj.b398 (Published 2 February 2009)
Cite this as: BMJ 2009;338:b398

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Martin Llewelyn, senior lecturer, infectious diseases and therapeutics1
  1. 1Brighton and Sussex Medical School (BSMS), University of Sussex, Brighton, East Sussex BN1 9PX
  1. m.j.llewelyn{at}bsms.ac.uk

    I thought that it might be helpful to set the record straight on the undergraduate curriculum at Brighton and Sussex Medical School (BSMS).1

    The student selected project on drug development is precisely that: student selected. It is not core material, and in fact comparatively …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular